Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.
about
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesThe current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neckp16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaTreatment of Elderly Patients with Squamous Cell Carcinoma of the Head and NeckDiagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.HPV-associated lung cancers: an international pooled analysis.Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomasPATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesIntensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivityDifferent prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequencyPrognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.Human papillomavirus and Epstein Barr virus in head and neck carcinomas: suggestions for the new WHO classification.Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples.Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.HPV Testing of Head and Neck Cancer in Clinical Practice.Tumor Staging and HPV-Related Oropharyngeal Cancer.Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC.The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.Human papillomavirus related oropharyngeal cancer.Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.Is immunohistochemical evaluation of p16 in oropharyngeal cancer enough to predict the HPV positivity?Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.Risk factors associated with competing mortality among patients with head and neck cancer in Japan.Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery.Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype.Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.Human papillomavirus in the nasopharynx: A true entity?The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck.HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients' survival.Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
P2860
Q26752584-78DA038D-AF40-4376-B17E-12FB8902E32AQ26830495-4C82CE25-210F-4C47-9EEA-342F260FDA97Q27853077-65331E82-34A4-4EA9-97A8-3C779FEAA602Q28076894-90F1324F-4733-46FE-A8A5-44B3B5300048Q33655046-830E5E9B-727C-41F3-A970-BE46D2CFA9DBQ33705253-3766B063-CC3D-4C81-A04B-D0B2AF908D88Q35052911-E27BAA76-7331-456A-9C7D-BE90B453ED22Q35756867-44A4C397-653B-4D20-B93E-6A6AFBD69B3DQ35838231-449ADF11-1C25-4FE6-9FB2-4540EF31274DQ36105656-C139078D-C26A-47C9-BAA7-C5FE48731307Q36285958-3DBC1D58-0761-41D1-A062-B10BD4EF8DE1Q36783066-9A517411-C6F4-4D89-981A-EEC51AB0B91BQ37376041-DE80680C-9B78-4631-8190-44A900538A2CQ38255620-9DBEA854-0DFF-4661-A5EC-963AD177F2FAQ38372482-A3624386-C436-4927-AE3E-516AD4FDF7CCQ38557897-D07978C1-DBB8-49CA-B081-5AC3F8A78F6BQ38653658-12A51151-ABB6-4F45-924B-3EA6F5147C66Q38971546-5E6F6DBC-1B53-4ED9-85F0-075E8281443EQ38971551-1AF8492D-001D-482E-B420-93C49E455EC1Q38971577-FB591EED-B087-4D0B-B6FE-684C333B44FAQ39352364-4501477F-F055-4866-BF2D-8AB1C22036A4Q40152615-6B5FB042-604F-400A-836E-BD7C0C58D948Q40214883-3F049065-EE2B-4F1A-BCDE-C3959EC043B5Q40219648-A61D6BC3-BCA2-4C70-9A76-CF2408D36D01Q40534462-D839FF83-6B0F-4D1F-AFCC-90958C57ABFAQ40571255-91AB8EA8-1A69-4231-8A63-851EBFC32E6FQ41075136-76F4DBFD-4767-4111-B1D1-7C7700222B31Q41372801-E060B319-0F4C-4E79-8FDA-7ECFE99F15F2Q41750160-72F01739-98BA-4714-B2EB-9236BE2CC40CQ42254654-825AB6C4-A161-42A0-BC5D-BC3582CF364EQ47106465-20E143E2-C0C4-488D-8A4B-055E00C7ECFBQ47214971-61F9F6A6-C565-49A5-BC28-3369A756E5B3Q47407081-3E436581-C943-4690-B5B4-3C8E494E9DF3Q47423331-00CC401C-EA79-40A6-80A4-00566C75B4D6Q48261359-941E18FC-DBC4-498B-80CD-4EC167076BE7Q48277339-F5585F06-5F84-430A-9B6B-80339BE09BCBQ51846059-F442997F-1435-4B34-A5DD-2F20A29EEDF8Q52583058-71B412CD-8A72-468B-B309-799D3339A62DQ53090717-18404B9E-2637-47CB-AFF3-6F68B920AC11Q55246604-1A8C7C8F-7537-458F-9A97-3E721A4A8F48
P2860
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Human papillomavirus detection ...... reatment De-escalation trials.
@en
Human papillomavirus detection ...... reatment De-escalation trials.
@nl
type
label
Human papillomavirus detection ...... reatment De-escalation trials.
@en
Human papillomavirus detection ...... reatment De-escalation trials.
@nl
prefLabel
Human papillomavirus detection ...... reatment De-escalation trials.
@en
Human papillomavirus detection ...... reatment De-escalation trials.
@nl
P2093
P2860
P356
P1433
P1476
Human papillomavirus detection ...... reatment De-escalation trials.
@en
P2093
C R Leemans
D A M Heideman
E Bloemena
M M Rietbergen
P J F Snijders
R H Brakenhoff
R J Baatenburg-de Jong
S Koljenovic
P2860
P304
P356
10.1093/ANNONC/MDT319
P577
2013-08-14T00:00:00Z